XML 67 R63.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidating Financial Information (Details 2) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Apr. 01, 2012
Apr. 03, 2011
Cash Flow from Operating Activities:    
Net cash provided by operating activities $ 68,860 $ 69,077
Cash Flow from Investing Activities:    
Acquisition, cash consideration, net of cash acquired   (409,607)
Proceeds from sale of property and equipment 158 250
Proceeds from sale of assets held for sale 297 0
Change in restricted cash and investments 791 3,199
Capital expenditures (48,832) (38,696)
Net cash used in investing activities (47,586) (444,854)
Cash Flow from Financing Activities:    
Payments on long-term debt (64,075) (21,666)
Proceeds from long-term debt 53,000 461,000
Distribution to noncontrolling interests (5,758) (4,012)
Proceeds from the exercise of stock options 231 983
Income tax (provision) benefit of equity compensation (342) 172
Debt issuance costs (44) (9,277)
Net cash (used in) provided by financing activities (18,023) 427,200
Effect of Exchange Rate Changes on Cash and Cash Equivalents 995 (5,193)
Net Increase in Cash and Cash Equivalents 4,246 46,230
Cash and Cash Equivalents, beginning of period 44,753 39,664
Cash and Cash Equivalents, end of period 48,999 85,894
The GEO Group Inc. [Member]
   
Cash Flow from Operating Activities:    
Net cash provided by operating activities 26,364 41,403
Cash Flow from Investing Activities:    
Acquisition, cash consideration, net of cash acquired   (409,607)
Proceeds from sale of property and equipment 0 0
Proceeds from sale of assets held for sale 0  
Change in restricted cash and investments 0 0
Capital expenditures (27,046) (33,312)
Net cash used in investing activities (27,046) (442,919)
Cash Flow from Financing Activities:    
Payments on long-term debt (57,278) (15,375)
Proceeds from long-term debt 53,000 461,000
Distribution to noncontrolling interests 0 0
Proceeds from the exercise of stock options 231 983
Income tax (provision) benefit of equity compensation (342) 172
Debt issuance costs (6) (9,277)
Net cash (used in) provided by financing activities (5,430) 437,503
Effect of Exchange Rate Changes on Cash and Cash Equivalents 0 0
Net Increase in Cash and Cash Equivalents (6,112) 35,987
Cash and Cash Equivalents, beginning of period 15,085 2,614
Cash and Cash Equivalents, end of period 8,973 38,601
Combined Subsidiary Guarantors [Member]
   
Cash Flow from Operating Activities:    
Net cash provided by operating activities 20,495 8,025
Cash Flow from Investing Activities:    
Acquisition, cash consideration, net of cash acquired   0
Proceeds from sale of property and equipment 149 250
Proceeds from sale of assets held for sale 297  
Change in restricted cash and investments 0 0
Capital expenditures (21,232) (4,848)
Net cash used in investing activities (20,786) (4,598)
Cash Flow from Financing Activities:    
Payments on long-term debt (340) (207)
Proceeds from long-term debt 0 0
Distribution to noncontrolling interests 0 0
Proceeds from the exercise of stock options 0 0
Income tax (provision) benefit of equity compensation 0 0
Debt issuance costs 0 0
Net cash (used in) provided by financing activities (340) (207)
Effect of Exchange Rate Changes on Cash and Cash Equivalents 0 0
Net Increase in Cash and Cash Equivalents (631) 3,220
Cash and Cash Equivalents, beginning of period 3,155 221
Cash and Cash Equivalents, end of period 2,524 3,441
Combined Non-Guarantor Subsidiaries [Member]
   
Cash Flow from Operating Activities:    
Net cash provided by operating activities 22,001 19,649
Cash Flow from Investing Activities:    
Acquisition, cash consideration, net of cash acquired   0
Proceeds from sale of property and equipment 9 0
Proceeds from sale of assets held for sale 0  
Change in restricted cash and investments 791 3,199
Capital expenditures (554) (536)
Net cash used in investing activities 246 2,663
Cash Flow from Financing Activities:    
Payments on long-term debt (6,457) (6,084)
Proceeds from long-term debt 0 0
Distribution to noncontrolling interests (5,758) (4,012)
Proceeds from the exercise of stock options 0 0
Income tax (provision) benefit of equity compensation 0 0
Debt issuance costs (38) 0
Net cash (used in) provided by financing activities (12,253) (10,096)
Effect of Exchange Rate Changes on Cash and Cash Equivalents 995 (5,193)
Net Increase in Cash and Cash Equivalents 10,989 7,023
Cash and Cash Equivalents, beginning of period 26,513 36,829
Cash and Cash Equivalents, end of period $ 37,502 $ 43,852